Japan-headquartered Atonarp has raised $50 million from a Series D funding round led by Silicon Valley-based investor WRVI Capital and supported by Furukawa Electric, Japan Post Investment, Boscolo Intervest, ATI Korea, and Banner Industries. This brings a total of $111 million in investments for the company.
WHAT IT DOES
Founded in 2010, Atonarp produces digital molecular diagnostic solutions...
The University of Oxford, Prenetics, a diagnostics and genetic testing company, and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to further develop OxLAMPTM technology, a molecular testing technology for infectious diseases.
Following the acquisition by Prenetics of Oxsed, an Oxford University spin-out company from October 2020, the aim has been to...
